Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) The NIH Office of Science Policy (OSP) within the Office of the Director (OD) announces the availability of administrative supplements to support 1) research on bioethical issues to develop or support the development of an evidence base that may inform future policy directions, and/or 2) certain efforts to develop or augment bioethics research capacity. Applicants may propose to supplement parent awards focused on bioethics or to add a component related to bioethics to a parent award in which bioethics was not the focus. Note that applications must be within the general scope of the parent award. Notice of NIH Participation in Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science The purpose of this Notice is to announce the collaboration between the NIH and the National Science Foundation (NSF) on an interagency funding opportunity, Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science. The initiative supports innovative, high-risk/high-reward research with the promise of disruptive transformations in biomedical research. Proposals submitted must make fundamental contributions to two or more disciplines, such as computer or information sciences, engineering, social, behavioral, biomedical, cognitive and/or economic sciences, to improve the fundamental understanding of biomedical and health related processes and address a key health problem. NIBIB has broad interests in the development of biomedical technologies to improve human health and address health disparities. Program areas of particular relevance include: data science and health information technologies, telehealth, mHealth, point-of-care technologies, medical image interpretation or perception, medical data/image visualization, artificial intelligence, machine learning and deep learning, clinical decision support system, rehabilitation engineering, robotics, and next generation predictive models. NIBIB is interested in the development of novel technologies and in advances that enable effective utilization of new or existing technologies. Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) Additional funds may be awarded as supplements to parent awards using the specific Activity Code(s). Note, however, that not all participating NIH Institutes and Centers (ICs) support all the activity codes listed below. Eligible Activity Codes and participating ICs can be found in the announcement. Applicants must therefore consult the Table of IC-Specific Information, Requirements and Staff Contacts for more details. Pre-Application Webinar for RFA-CA-20-054, Collaborative Approaches to Engineer Biology for Cancer Applications (U01 Clinical Trial Not Allowed) The NCI and NIBIB will hold a pre-application webinar for RFA-CA-20-054 "Collaborative Approaches to Engineer Biology for Cancer Applications (U01 Clinical Trial Not Allowed)" on Thursday, December 10, 2020 from 1:00 - 2:00 p.m. ET. The intent of the webinar is to provide an overview of the funding opportunity (RFA-CA-20-054), including details on the research focus and responsiveness criteria, and to address questions pertinent to preparing applications. Participation in this webinar, although encouraged, is optional and is not required for application submission. Please submit questions in advance, no later than December 4, 2020, to Michelle Berny-Lang, michelle.berny-lang@nih.gov. Please indicate "RFA-CA-20-054 webinar" in the subject line of your email. Attendees will also be able to ask questions during the webinar. Questions submitted in advance will be answered first. Following the webinar, attendees and prospective applicants can view a copy of webinar slides and the webinar recording here: cssi.cancer.gov/synbio | 
No comments:
Post a Comment